Ameritas Advisory Services
MRVI icon

Ameritas Advisory Services’s Maravai LifeSciences MRVI Stock Holding History

Ameritas Advisory Services’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.46K Hold
713
– – ﹤0.01% 1587
2026
Q2 		$4.45K Buy
+713
New +$3.08K ﹤0.01% 1588

Other funds holding MRVI

GTCR LLC
GTCR LLC Chicago, Illinois $4.29B AUM 4.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Ameritas Advisory Services's MRVI Position: Q3 2026 in Review

Ameritas Advisory Services held its Maravai LifeSciences (MRVI) position steady in Q3 2026 at 713 shares worth $5.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

Ameritas Advisory Services first reported a position in MRVI in Q2 2026 and has held it in 2 quarters since. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Ameritas Advisory Services held 713 shares of Maravai LifeSciences worth $5.46K as of Q3 2026.
  • Ameritas Advisory Services left its Maravai LifeSciences share count unchanged in Q3 2026.
  • Maravai LifeSciences made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1587 holding.
  • Ameritas Advisory Services first reported a position in Maravai LifeSciences in Q2 2026 and has held it in 2 quarters since.
  • 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.